You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

BACITRACIN-NEOMYCIN-POLYMYXIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Bacitracin-neomycin-polymyxin patents expire, and when can generic versions of Bacitracin-neomycin-polymyxin launch?

Bacitracin-neomycin-polymyxin is a drug marketed by Pharmaderm, Altana, and Padagis Us. and is included in three NDAs.

The generic ingredient in BACITRACIN-NEOMYCIN-POLYMYXIN is bacitracin zinc; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the bacitracin zinc; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for BACITRACIN-NEOMYCIN-POLYMYXIN?
  • What are the global sales for BACITRACIN-NEOMYCIN-POLYMYXIN?
  • What is Average Wholesale Price for BACITRACIN-NEOMYCIN-POLYMYXIN?
Summary for BACITRACIN-NEOMYCIN-POLYMYXIN
US Patents:0
Applicants:3
NDAs:3
DailyMed Link:BACITRACIN-NEOMYCIN-POLYMYXIN at DailyMed
Drug patent expirations by year for BACITRACIN-NEOMYCIN-POLYMYXIN

US Patents and Regulatory Information for BACITRACIN-NEOMYCIN-POLYMYXIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmaderm BACITRACIN-NEOMYCIN-POLYMYXIN bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 062167-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Altana BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE bacitracin; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 060731-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Padagis Us BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE bacitracin zinc; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 062166-002 Approved Prior to Jan 1, 1982 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.